Post-COVID pain and quality of life in COVID-19 patients: protocol for a meta-analysis and systematic review

Introduction During the COVID-19 pandemic, approximately 10%–35% of COVID-19 infected patients experience post-COVID sequela. Among these sequelae, pain symptoms should not be neglected. In addition, the sequelae of COVID-19 also decrease the quality of life of these populations. However, meta-analy...

Full description

Saved in:
Bibliographic Details
Main Authors: Yongxing Xu, Jianwen Gu, Mengrong Miao, Yitian Yang, Pule Li, Mengqi Jia, Zhaoyu Wen, Mengmeng Yu, Jiaqiang Zhang
Format: Article
Language:English
Published: BMJ Publishing Group 2022-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/7/e057394.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575907483615232
author Yongxing Xu
Jianwen Gu
Mengrong Miao
Yitian Yang
Pule Li
Mengqi Jia
Zhaoyu Wen
Mengmeng Yu
Jiaqiang Zhang
author_facet Yongxing Xu
Jianwen Gu
Mengrong Miao
Yitian Yang
Pule Li
Mengqi Jia
Zhaoyu Wen
Mengmeng Yu
Jiaqiang Zhang
author_sort Yongxing Xu
collection DOAJ
description Introduction During the COVID-19 pandemic, approximately 10%–35% of COVID-19 infected patients experience post-COVID sequela. Among these sequelae, pain symptoms should not be neglected. In addition, the sequelae of COVID-19 also decrease the quality of life of these populations. However, meta-analyses that systematically evaluated post-COVID pain are sparse.Methods and analysis A comprehensive screening will be performed by searching MEDLINE and Embase without language restriction from inception to August 2021. Cohort studies, case–control studies, cross-sectional studies and case series will be included. Case report and interventional studies will be excluded. Studies with less than 20 participants will be also excluded. We aim to investigate the prevalence of pain-related symptoms in patients after the acute phase of COVID-19. The impact of COVID-19 on the quality of life and pain symptoms among these populations in the post-acute phase will also be evaluated. ROBINS-I tool will be used to assess the risk of bias of cohort studies. The risk of bias tool developed by Hoy et al will be used to assess the risk of bias of prevalence studies. Metaprop command in Stata will be used to estimate the pooled prevalence of pain symptoms. DerSimonian and Laird random-effects models will be used to calculate the pooled relative risks. All analyses will be calculated using Stata software (V.15.0; StataCorp)Ethics and dissemination Ethics approval is not required. Results of our study will be submitted to a peer-review journal.PROSPERO registration number CRD42021272800.
format Article
id doaj-art-33d0fdaf14394019bce1ba2acdb3a02c
institution Kabale University
issn 2044-6055
language English
publishDate 2022-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-33d0fdaf14394019bce1ba2acdb3a02c2025-01-31T16:15:14ZengBMJ Publishing GroupBMJ Open2044-60552022-07-0112710.1136/bmjopen-2021-057394Post-COVID pain and quality of life in COVID-19 patients: protocol for a meta-analysis and systematic reviewYongxing Xu0Jianwen Gu1Mengrong Miao2Yitian Yang3Pule Li4Mengqi Jia5Zhaoyu Wen6Mengmeng Yu7Jiaqiang Zhang8Department of Nephrology, People`s Liberation Army Strategic Support Force Medical Center, Beijing, ChinaThe Leading Group on COVID-19 Prevention and Control, People`s Liberation Army Strategic Support Force Medical Center, Beijing, ChinaZhengzhou University, Zhengzhou, Henan, ChinaZhengzhou University, Zhengzhou, Henan, ChinaDepartment of Anesthesiology and Perioperative Medicine, Henan Provincial People`s Hospital, People`s Hospital of Zhengzhou University, People`s Hospital of Henan University, Zhengzhou, Henan, ChinaDepartment of Anesthesiology and Perioperative Medicine, Henan Provincial People`s Hospital, People`s Hospital of Zhengzhou University, People`s Hospital of Henan University, Zhengzhou, Henan, ChinaDepartment of Anesthesiology and Perioperative Medicine, Henan Provincial People`s Hospital, People`s Hospital of Zhengzhou University, People`s Hospital of Henan University, Zhengzhou, Henan, ChinaDepartment of Anesthesiology and Perioperative Medicine, Henan Provincial People`s Hospital, People`s Hospital of Zhengzhou University, People`s Hospital of Henan University, Zhengzhou, Henan, ChinaDepartment of Anesthesiology and Perioperative Medicine, Henan Provincial People`s Hospital, Zhengzhou, Henan, ChinaIntroduction During the COVID-19 pandemic, approximately 10%–35% of COVID-19 infected patients experience post-COVID sequela. Among these sequelae, pain symptoms should not be neglected. In addition, the sequelae of COVID-19 also decrease the quality of life of these populations. However, meta-analyses that systematically evaluated post-COVID pain are sparse.Methods and analysis A comprehensive screening will be performed by searching MEDLINE and Embase without language restriction from inception to August 2021. Cohort studies, case–control studies, cross-sectional studies and case series will be included. Case report and interventional studies will be excluded. Studies with less than 20 participants will be also excluded. We aim to investigate the prevalence of pain-related symptoms in patients after the acute phase of COVID-19. The impact of COVID-19 on the quality of life and pain symptoms among these populations in the post-acute phase will also be evaluated. ROBINS-I tool will be used to assess the risk of bias of cohort studies. The risk of bias tool developed by Hoy et al will be used to assess the risk of bias of prevalence studies. Metaprop command in Stata will be used to estimate the pooled prevalence of pain symptoms. DerSimonian and Laird random-effects models will be used to calculate the pooled relative risks. All analyses will be calculated using Stata software (V.15.0; StataCorp)Ethics and dissemination Ethics approval is not required. Results of our study will be submitted to a peer-review journal.PROSPERO registration number CRD42021272800.https://bmjopen.bmj.com/content/12/7/e057394.full
spellingShingle Yongxing Xu
Jianwen Gu
Mengrong Miao
Yitian Yang
Pule Li
Mengqi Jia
Zhaoyu Wen
Mengmeng Yu
Jiaqiang Zhang
Post-COVID pain and quality of life in COVID-19 patients: protocol for a meta-analysis and systematic review
BMJ Open
title Post-COVID pain and quality of life in COVID-19 patients: protocol for a meta-analysis and systematic review
title_full Post-COVID pain and quality of life in COVID-19 patients: protocol for a meta-analysis and systematic review
title_fullStr Post-COVID pain and quality of life in COVID-19 patients: protocol for a meta-analysis and systematic review
title_full_unstemmed Post-COVID pain and quality of life in COVID-19 patients: protocol for a meta-analysis and systematic review
title_short Post-COVID pain and quality of life in COVID-19 patients: protocol for a meta-analysis and systematic review
title_sort post covid pain and quality of life in covid 19 patients protocol for a meta analysis and systematic review
url https://bmjopen.bmj.com/content/12/7/e057394.full
work_keys_str_mv AT yongxingxu postcovidpainandqualityoflifeincovid19patientsprotocolforametaanalysisandsystematicreview
AT jianwengu postcovidpainandqualityoflifeincovid19patientsprotocolforametaanalysisandsystematicreview
AT mengrongmiao postcovidpainandqualityoflifeincovid19patientsprotocolforametaanalysisandsystematicreview
AT yitianyang postcovidpainandqualityoflifeincovid19patientsprotocolforametaanalysisandsystematicreview
AT puleli postcovidpainandqualityoflifeincovid19patientsprotocolforametaanalysisandsystematicreview
AT mengqijia postcovidpainandqualityoflifeincovid19patientsprotocolforametaanalysisandsystematicreview
AT zhaoyuwen postcovidpainandqualityoflifeincovid19patientsprotocolforametaanalysisandsystematicreview
AT mengmengyu postcovidpainandqualityoflifeincovid19patientsprotocolforametaanalysisandsystematicreview
AT jiaqiangzhang postcovidpainandqualityoflifeincovid19patientsprotocolforametaanalysisandsystematicreview